Wire Cerclage Sternal Closure Systems Market Size, Share, Analysis 2034
The Global Wire Cerclage Sternal Closure Systems Market has witnessed continuous growth in the last few years and is projected to grow even further during the forecast period of 2024-2033. The assessment provides a 360° view and insights - outlining the key outcomes of the Wire Cerclage Sternal Closure Systems market, current scenario analysis that highlights slowdown aims to provide unique strategies and solutions following and benchmarking key players strategies. In addition, the study helps with competition insights of emerging players in understanding the companies more precisely to make better informed decisions.
Browse for Full Report at @ https://www.thebrainyinsights.com/report/wire-cerclage-sternal-closure-systems-market-13471
🏢 Reference Companies & Market Size
Global Market Size (2022): ~USD 2.3 billion
Projected Size (2027): ~USD 2.9 billion at a CAGR of ~5.1% between 2022–2027
Key Players in the sternal closure systems market (which includes wire cerclage devices):
DePuy Synthes (Johnson & Johnson, US)
Zimmer Biomet (US)
KLS Martin Group (Germany)
Acute Innovations LLC (US)
A&E Medical Corporation (US)
Kinamed Inc (US)
JACE Medical LLC (US)
Dispomedica GmbH (Germany)
ABYRX Inc (US)
Waston Medical Corporation (China)
Orthofix, Idear SRL, B. Braun, Teleflex, Jeil Medical, Sklar Surgical
In 2020, Zimmer Biomet acquired A&E Medical for USD 250 million, bolstering its sternal closure portfolio
🆕 Recent Developments
Evonik Venture Capital invested in startup CircumFix Solutions (2022) to develop a PEEK-based sternal closure instrument improving recovery post-surgery
In 2021, NEOS Surgery unveiled the STERN Fix device—an implant made of carbon‑PEEK matrix—at the European Association for CardioThoracic Surgery meeting in Barcelona
FDA granted 510(k) clearance in 2021 for Able Medical Devices’ Valkyrie Thoracic Fixation System, expanding application in sternotomy closure and chest wall stabilization .
🚀 Drivers
Increasing number of heart surgeries and sternotomy procedures, notably CABG (~400,000 annually worldwide), driving demand for wire cerclage systems
FDA approvals and new product innovations, making closure devices safer and more reliable (e.g., Valkyrie system) .
Preference for wire-based closure due to ease of use, cost-effectiveness, and relatively low complication rates compared to other techniques
⚠️ Restraints
Complications linked to wire cerclage, such as wire breakage, sternal cut-through, non-union, and postoperative pain, leading to increased morbidity and costs
Physiologic micromovement between sternal halves, which may delay healing or lead to separation under load—even though minimal movement can enhance callus formation in healthy bones .
🌍 Regional Segmentation Analysis
North America dominates with ~36–36.3% market share in 2022 due to high surgical volume, strong healthcare infrastructure, favorable reimbursement (e.g., Medicare coding), and established players like DePuy and Zimmer Biomet .
Asia-Pacific projected to grow fastest, propelled by rising healthcare infrastructure investment and growing volume of thoracic surgeries in countries like China, India, and South Korea .
Europe, Latin America & MEA show moderate growth, constrained by slower procedure growth and stricter device regulations .
🔥 Emerging Trends
Wire closure segment remains largest, accounting for ~70–73% share of closure-device types in 2022 .
Rising use of titanium and PEEK materials due to biocompatibility, MRI compatibility, and better osteointegration over traditional steel wire—Titanium segment held ~36% share in 2022 .
Plate-screw, cable, clip systems gaining traction via innovations (e.g. Sternal ZIPFIX, Talon, SternaLock Blu/360 systems) from Zimmer Biomet, DePuy Synthes, KLS Martin, Orthofix, and others .
🏷️ Top Use Cases
Median sternotomy procedures, the predominant sternal opening technique (approx. 38.9% share in 2022) .
Other applications include hemisternotomy and bilateral thoracosternotomy, particularly in pediatric and complex surgeries .
🛑 Major Challenges
Clinical complications and patient outcomes concerns: Non-union, infections, prolonged hospitalization due to failed closures.
Adoption of alternative systems: Plate/cable-based systems may offer improved mechanical stability but at higher cost.
Regulatory and clinical validation burden for novel materials (PEEK) and systems, requiring thorough testing and longer approval timelines.
💡 Attractive Opportunities
Healthcare infrastructure build-out in emerging economies, opening high volume markets for standard wire systems. Using titanium or PEEK can offer premium positioning. .
Material innovation: Increasing use of titanium and PEEK closures to reduce complications and enable MRI compatibility. .
Collaborations and acquisitions—like Zimmer Biomet’s purchase of A&E Medical—may bring new technologies and expand coverage. .
📈 Key Factors for Market Expansion
Rising cardiothoracic surgery volume, especially in aging populations.
Regulatory approvals for next-gen closure systems (e.g. PEEK-based implants, titanium devices).
Reimbursement structures supporting advanced closure devices in major markets.
OEM innovation and M&A activity fueling enhanced product portfolios.
Education and surgeon adoption, promoting understanding of benefits of advanced closure technology to improve outcomes.
Let me know if you’d like company-specific profiles (e.g. Zimmer Biomet’s ZIPFIX, DePuy’s
Comments
Post a Comment